Current price is less than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Natco Pharma (₹699.1): SELL

Natco Pharma Ltd is quoting at Rs 824.45, up 3.41% on the day as on 12:54 IST on the NSE. The stock is down 0.74% in last one year as compared to a 22.63% jump in NIFTY and a 10.4% jump in the Nifty Pharma index.

Natco Pharma Ltd continues to edge higher

Stocks in news: Future Enterprises, TCS, Tata Motors, Larsen and Toubro, Ashok Leyland, Dish TV, Natco Pharma and more

Stocks in news: TCS, Tata Motors, L&T, Future Enterprises and more

Natco Pharma stock rose 8.97 per cent to Rs 920 against the previous close of Rs 844.30 on BSE. Market cap of the firm climbed to Rs 15,953 crore.

Natco Pharma stock zooms 9% on launch of first generic version of Revlimid in US

Natco Pharma rose 4% to Rs 881.35 after the company announced the launch of the first generic version of Revlimid (lenalidomide capsules) in the US market.

Natco Pharma jumps on launching Revlimid generic in US mkt

In the past three months, Natco Pharma has outperformed the market by gaining 8 per cent, as compared to 8 per cent decline in the S&P BSE Sensex.

Natco Pharma gains 9% as firm launches generic version of Revlimid in US

The share touched a 52-week high of Rs 1,188.95 and a 52-week low of Rs 750.45 on 24 May, 2021 and 24 February, 2022, respectively.

Natco Pharma share price rises 9% on launch of generic of Revlimid in US

Buzzing stocks: Dish TV, Tata Motors, Natco Pharma, Vijaya Diagnostic, GE Shipping, Dodla Dairy

Stocks that will see action today (March 8)

Tata Consultancy Services (TCS): TCS has been positioned as a Leader in the Everest Group PEAK Matrix for Mortgage Operations. The report highlights TCS’ stronghold of mortgage operations across geographies, covering the entire value chain from

TCS, GE Shipping, Natco Pharma in focus

Revlimid had annual sales of $2.3 billion as of December 2021, according to IQVIA data. The generic version of Revlimid will be available in 5mg, 10mg, 15mg, and 25mg strengths. The announcement came after market hours. The Shares of Natco Pharma 2.98% to close at Rs 844.30 on BSE on Monday, the ben…

Natco Pharma announces launch of first generic of top selling cancer drug Revlimid

Natco Pharma Ltd is quoting at Rs 800.25, down 2.99% on the day as on 13:24 IST on the NSE. The stock jumped 17.07% in last one year as compared to a 9.07% rally in NIFTY and a 3.52% spurt in the Nifty Pharma index.

Natco Pharma Ltd falls around 3%

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Natco Pharma Ltd

Natco Pharma Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Natco Pharma (₹699.1): SELL

Natco Pharma Ltd continues to edge higher

Stocks in news: TCS, Tata Motors, L&T, Future Enterprises and more

Natco Pharma stock zooms 9% on launch of first generic version of Revlimid in US

Natco Pharma jumps on launching Revlimid generic in US mkt

Natco Pharma gains 9% as firm launches generic version of Revlimid in US

Natco Pharma share price rises 9% on launch of generic of Revlimid in US

Natco Pharma Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Natco Pharma (₹699.1): SELL

Natco Pharma Ltd continues to edge higher

Stocks in news: TCS, Tata Motors, L&T, Future Enterprises and more

Natco Pharma stock zooms 9% on launch of first generic version of Revlimid in US

Natco Pharma jumps on launching Revlimid generic in US mkt

Natco Pharma gains 9% as firm launches generic version of Revlimid in US

Natco Pharma share price rises 9% on launch of generic of Revlimid in US

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock